ongoing trials trial from other registries Evaluation the effects of camel milk in spirometry parameters in over 6 yearâs children with Cystic Fibrosis lung disease - Recruiting Year: 2022 Date: Author: Source http://en.irct.ir/trial/60180 Participants Principal inclusion criteria: 1. Subject (or the subjectâs legally appointed and authorized representative) will sign and date an informed consent form (ICF) and, when appropriate, an assent form. Interventions Elexacaftor (ELX)/tezacaftor (TEZ)/ivacaftor (IVA) Outcome measures Primary end point(s): Safety and tolerability based on AEs, clinical laboratory values, ECGs, vital signs, and pulse oximetry